MYC promotes uncontrolled proliferation of tumor cells by activating cyclin-dependent kinase 4 in cell cycle S-phase entry 40 and fuels metabolic reprogramming via aerobic glycolysis or biosynthetic intermediate production 41. This evidence concerns the gene CDK4 and neoplasm.